ArticleThe Journal of urology2022

Exploring Variation in the Receipt of Recommended Active Surveillance for Men with Favorable-Risk Prostate Cancer.

Archana Radhakrishnan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.